NEWRON PHARMACEUT. EO-20 (NP5) — Free Cash Flow Generation Index
NEWRON PHARMACEUT. EO-20 (NP5) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of €33.32 Million represents 1% of operating cash flow (€33.60 Million). Read NEWRON PHARMACEUT. EO-20 balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NEWRON PHARMACEUT. EO-20 Free Cash Flow Generation Index (2012–2025)
Historical FCF Generation Index trend for NEWRON PHARMACEUT. EO-20 across 2 annual periods. Explore NEWRON PHARMACEUT. EO-20 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for NEWRON PHARMACEUT. EO-20 (2012–2025)
Year-by-year Free Cash Flow Generation Index for NEWRON PHARMACEUT. EO-20. For the full company profile including market capitalisation, see NP5 market cap.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | €32.52 Million | €32.56 Million | €47.31K | ▲ +0.0% |
| 2012 | 1.00x | €5.81 Million | €5.83 Million | €11.00K | — |